Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06058195
Other study ID # 03.03.2023/372
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 3, 2023
Est. completion date February 16, 2024

Study information

Verified date January 2024
Source Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Contact Fatma Acil
Phone +905337225225
Email acilfatma@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients who will undergo laparoscopic gallbladder surgery are expected to experience less postoperative pain and have less need for morphine-derived painkillers. For this reason, a total of 128 patients were planned to be included in the study, including a group of patients who were eligible for gallbladder surgery with transverse abdominis plane block (TAPB), a group of patients with quadratus lumborum plane block (QLB) and a group of patients with intravenous painkillers (IVA).


Description:

1. Group QLB (Quadratus lumborum plane block): 20 ml of 0.25% bupivacaine will be used each time for plane block on both sides. Patients will be sedated with 1 mg midazolam and 50 mcg fentanyl intravenously in the preoperative preparation room in the operating room and 20 ml of 0.25% bupivacaine was administered bilaterally on each side under ultrasound guidance. After the block application, the patient was taken to the operating room and standard general anaesthesia was applied. Patients will not be given any analgesic medication before awakening from anaesthesia. 2. Group TAPB (Transverse abdominis plane block): 20 ml of 0.25% bupivacaine will be used each time for plane block on both sides. Patients will be sedated with 1 mg midazolam and 50 mcg fentanyl intravenously in the preoperative preparation room in the operating room and 20 ml of 0.25% bupivacaine was administered bilaterally on each side under ultrasound guidance. After the block application, the patient was taken to the operating room and standard general anaesthesia was applied. Patients will not be given any analgesic medication before awakening from anaesthesia. For both Group QLB and Group TAPB block group; - Medical records will be audited to monitor adherence to the intervention. - each patient will be administered 0.25% bupivacaine for each side (a total of 40 ml of 0.25% bupivacaine will be used) - plane blocks will be applied under ultrasound guidance. - plane block applications will be performed by anaesthesiologists with at least 5 years of experience - Postoperative evaluations of patients will be performed face to face. - Plane block applications will be applied only once in the preoperative period. - In the postoperative period, 1000 mg paracetamol will be given intravenously if the pain intensity of the patients is below Visual Analogue Scale (VAS) 4. However, if the severity of pain is VAS 4 and above, 100 mg tramadol will be given intravenously. - This study will be followed up in the general surgery unit. - Patients will be monitored for pain and side effects at 30th minute, 2nd hour, 4th hour, 12th hour and 24th hour in the postoperative period. - Both plane blocks are applied for analgesia in the postoperative period and aim to reduce opioid consumption in the postoperative period. 3. Group IVA (Intravenous analgesia): These patients will be administered 1000 mg paracetamol intravenously in the preoperative waiting room in the operating room approximately 20-30 minutes before induction of anaesthesia. No block procedure will be performed. Patients will not be given any analgesic medication before awakening from anaesthesia. - Postoperative evaluations of patients will be performed face to face. - Plane block applications will be applied only once in the preoperative period. - In the postoperative period, 1000 mg paracetamol will be given intravenously if the pain intensity of the patients is below Visual Analogue Scale (VAS) 4. However, if the severity of pain is VAS 4 and above, 100 mg tramadol will be given intravenously. - This study will be followed up in the general surgery unit. - Patients will be monitored for pain and side effects at 30th minute, 2nd hour, 4th hour, 12th hour and 24th hour in the postoperative period. Statistical methods / analysis: Power analysis (G-Power version 3.1.9.4 (University Kiel, Germany) program was used to calculate the sample size. The two-tailed alpha error was taken as 0.05, power as 0.80 and effect size as 0.8, and based on a previous study the allocation ratio was accepted as N2/N1:1. The minimum number of patients to be included in the study was calculated as 52. SPSS 16.0 for Windows (SPSS Inc., Chicago, USA) was used for other statistical analyses. Statistical data were expressed as mean and standard deviation, while categorical data were expressed as frequency and percentage. Comparison of categorical data in the groups was done with Chi-square, the results were given as %n. Shapiro-Wilk tests were used to determine if the numerical data fit the normal distribution. While the data fitting the normal distribution were evaluated with the Student's t-test. Mann- Whitney U tests were used to compare the data differ from the normal distribution. p <0.05 was considered statistically significant.


Recruitment information / eligibility

Status Recruiting
Enrollment 128
Est. completion date February 16, 2024
Est. primary completion date February 15, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Aged 18-70 years, - who will undergo laparoscopic cholecystectomy and who meet the American Society of Anesthesiologists (ASA) I-III physical status Exclusion Criteria: - American Society of Anesthesiologists (ASA) physical status above 3 - Age < 18 or >70 years - patient's reluctance

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Quadratus lumborum plane block
QLB (quadratus lumborum plane block): 20 ml of 0.25% bupivacaine will be used each time for plane block on both sides. Patients will be sedated with 1 mg midazolam and 50 mcg fentanyl intravenously in the preoperative preparation room in the operating room and 20 ml of 0.25% bupivacaine was administered bilaterally on each side under ultrasound guidance. After the block application, the patient was taken to the operating room and standard general anaesthesia was applied.
Transverse abdominis plane block
TAPB (transverse abdominis plane block): 20 ml of 0.25% bupivacaine will be used each time for plane block on both sides. Patients will be sedated with 1 mg midazolam and 50 mcg fentanyl intravenously in the preoperative preparation room in the operating room and 20 ml of 0.25% bupivacaine was administered bilaterally on each side under ultrasound guidance. After the block application, the patient was taken to the operating room and standard general anaesthesia was applied.
Intravenous analgesia
IVA (Intravenous analgesia): These patients will be administered 1000 mg paracetamol intravenously in the preoperative waiting room in the operating room approximately 20-30 minutes before induction of anaesthesia. No block procedure will be performed. Patients will not be given any analgesic medication before awakening from anaesthesia.

Locations

Country Name City State
Turkey Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital Diyarbakir

Sponsors (1)

Lead Sponsor Collaborator
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Verma K, Malawat A, Jethava D, Jethava DD. Comparison of transversus abdominis plane block and quadratus lumborum block for post-caesarean section analgesia: A randomised clinical trial. Indian J Anaesth. 2019 Oct;63(10):820-826. doi: 10.4103/ija.IJA_61_19. Epub 2019 Oct 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary VAS value of abdominal pain The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." 30 minutes, 2 hours, 4 hours, 12 hours, 24 hours after the patient is extubated
Primary postoperative total tramadol consumption Amount of tramadol used postoperatively (milligrams). If the VAS value of the patients is 4 and above, 100 mg tramadol is administered intravenously. during the first 24 hours after surgery.
Secondary Sedation- agitation level The Richmond Agitation Sedation Scale (RASS): identifies seven levels of sedation and agitation, which range from dangerous agitation to deep sedation, with a thorough description of patient behavior.
The Richmond Agitation Sedation Scale (RASS) is a 10-point scale ranging from -5 to +4.Levels -1 to -5 denote 5 levels of sedation, starting with "awakens to voice" and ending with "unarousable." Levels +1 to +4 describe increasing levels of agitation. The lowest level of agitation starts with apprehension and anxiety, and peaks at combative and violent. RASS level 0 is "alert and calm.
during extubation
Secondary amount of fentanyl consumed during the operation micrograms of fentanyl consumed during surgery during surgery
Secondary nausea-vomiting questioning about the presence/absence of nausea and/or vomiting in the postoperative period 30 minutes, 2 hours, 4 hours, 12 hours, 24 hours after the patient is extubated
Secondary postoperative shoulder pain shoulder pain patients will be asked to verbally assess whether there is pain or not 30 minutes, 2 hours, 4 hours, 12 hours, 24 hours after the patient is extubated
Secondary surgical duration Time in hours from the start of the surgical incision until the last surgical suture is placed at the end of surgery
Secondary anaesthesia duration time in hours from induction of anaesthesia to extubation at the end of anaesthesia
Secondary length of hospital stay days of hospitalisation after the operation It is assessed for up to 12 months from the date of surgery to the date of the first documented progression or the date of death from any cause, whichever comes first
See also
  Status Clinical Trial Phase
Completed NCT04852016 - Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy N/A
Withdrawn NCT00979186 - A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance N/A
Enrolling by invitation NCT02983474 - Korea Surgical Quality Improvement Program N/A
Recruiting NCT05089526 - Opioid-free Anesthesia in Laparoscopic Cholecystectomies N/A
Completed NCT04300985 - Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening. Phase 3
Recruiting NCT03817541 - Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients N/A
Completed NCT03577873 - RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones N/A
Completed NCT04270357 - Surgical Practices in Algeria : the Cholecystectomy
Completed NCT00689663 - Laparoscopic Cholecystectomy - Fundus First and Harmonic Ace Compared With Conventional Technique N/A
Recruiting NCT06447545 - Comparison Between Low Pressure Pneumoperitoneum With High Pressure Pneumoperitoneum in Post-operative Pain, Shoulder Tip Pain and Common Bile Duct Injuries in Patients Undergoing Laparoscopic Cholecystectomy N/A
Completed NCT03510923 - Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
Completed NCT03329859 - Microcomplications in Lap. Cholecystectomy: Reducing Intraoperative Interruptions by High Resolution Standardization N/A
Terminated NCT02163239 - Post Market Study for FloShield 10mm Reusable Cannula and Blunt Obturator and Robotic FloShield N/A
Completed NCT02085902 - Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery? Phase 4
Completed NCT06468735 - The Relationship Among Sarcopenia, Preperitoneal Fat Thickness and Cholecystectomy N/A
Completed NCT05681338 - Effect of the Coughing Technique During Subcutaneous Heparin Injection N/A
Completed NCT06020768 - The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position N/A
Completed NCT01211743 - Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy Phase 4
Completed NCT06028061 - Evaluation of Effectivity of Quadratus Lumborum Blocks With Adjuvant N/A
Completed NCT05366907 - Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.